The Spanish Competition Authority clears the acquisition of a pharmaceutical company by a rival subject to commitments to abolish rules which require minimum purchase orders and minimum period of permanence (Hefame / Cofarcu)

The CNMC cleared 11 mergers in October* All but one were approved in the first phase and without commitments, as they did not pose problems for competition in the affected markets. The Hefame/Cofarcu merger was approved in the first phase with commitments. The sectors affected by these corporate transactions were the following: pharmaceutical manufacturing, passenger air transport, insurance, reinsurance, pension funds and electricity production, among others. Madrid, 10 October 2022.- The CNMC approved a total of 11 mergers between companies in October. All of them were approved in the first phase and without commitments, with the exception of the Hefame/Cofarcu operation, which required a series of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Spanish Competition Authority, The Spanish Competition Authority clears the acquisition of a pharmaceutical company by a rival subject to commitments to abolish rules which require minimum purchase orders and minimum period of permanence (Hefame / Cofarcu), 10 October 2022, e-Competitions November 2022 - II, Art. N° 109492

Visites 38

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues